“Severe-controlled” asthma 4 years later: is it still controlled?

References

• Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock IM, Bateman ED, Bel EH, Bleecker ER, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–373. doi:10.1183/09031936.00202013.
   PubMed Web of Science ®Google Scholar
• Boulet LP, Devlin H, O’Donnell DE. The Physicians’ Practice Assessment Questionnaire on asthma and COPD. Resp Med. 2011;105(1):8–14. doi:10.1016/j.rmed.2010.07.022.
   PubMed Web of Science ®Google Scholar
• Murphy KR, Meltzer EO, Blaiss MS, Nathan RA, Stoloff SW, Doherty DE. Asthma management and control in the United States: results of the 2009 asthma insight and management survey. Allergy Asthma Proc. 2012;33(1):54–64. doi:10.2500/aap.2011.32.3518.
   PubMed Web of Science ®Google Scholar
• Varsano S, Segev D, Shitrit D. Severe and non-severe asthma in the community: a large electronic database analysis. Respir Med. 2017;123:131–139. doi:10.1016/j.rmed.2016.12.017.
   PubMed Web of Science ®Google Scholar
• Gershon AS, Victor JC, Guan J, Aaron SD, To T. Pulmonary function testing in the diagnosis of asthma: a population study. Chest. 2012;141(5):1190–1196. doi:10.1378/chest.11-0831.
   PubMed Web of Science ®Google Scholar
• Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA, Kosinski M, Pendergraft TB, Jhingran P. Asthma control test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. Allergy Clin Immunol. 2006;117(3):549–556. doi:10.1016/j.jaci.2006.01.011.
   Google Scholar
• Global Strategy for Asthma Management and Prevention. Chapter 2. Assessment of asthma (p. 22; Box 3-5, p. 31). 2014. Available from: https://ginasthma.org/wp-content/uploads/2019/01/2014-GINA.pdf [last accessed 17 April 2020].
   Google Scholar
• National Heart, Blood, and Lung Institute Expert Panel report 3 (EPR 3): Guidelines for the Diagnosis and management of Asthma. NIH publication no. 08-5846 (p. 43); 2007.
   Google Scholar
• Bousquet J, Heinzerling L, Bachert C, Papadopoulos NG, Bousquet PJ, Burney PG, Canonica GW, Carlsen KH, Cox L, Haahtela T, et al. Global allergy and asthma European network; allergic rhinitis and its impact on asthma. Practical guide to skin prick tests in allergy to aeroallergens. Allergy. 2012;67(1):18–24. doi:10.1111/j.1398-9995.2011.02728.x.
   PubMed Web of Science ®Google Scholar
• Al-Mughales JA. Diagnostic utility of total IgE in foods, inhalant, and multiple allergies in Saudi Arabia. J Immunol Res. 2016;2016:1–7. doi:10.1155/2016/1058632.
   Web of Science ®Google Scholar
• Carosso A, Bugiani M, Migliore E, Antò JM, DeMarco R. Reference values of total serum IgE and their significance in the diagnosis of allergy in young European adults. Int Arch Allergy Immunol. 2007;142(3):230–238. doi:10.1159/000097025.
   PubMed Web of Science ®Google Scholar
• Liang B, Yi Q, Feng Y. Association of gastroesophageal reflux disease with asthma control. Dis Esophagus. 2013;26(8):794–798. doi:10.1111/j.1442-2050.2012.01399.x.
   PubMed Web of Science ®Google Scholar
• Global initiative for Asthma. Global Strategy for Asthma management and Prevention, 2018. Available from: www.ginasthma.org/.
   Google Scholar
• Harding SM, Guzzo MR, Richter JE. The prevalence of gastroesophageal reflux in asthma patients without reflux symptoms. Am J Respir Crit Care Med. 2000;162(1):34–39. doi:10.1164/ajrccm.162.1.9907072.
   PubMed Web of Science ®Google Scholar
• Field SK, Underwood M, Brant R, Cowie RL. Prevalence of gastroesophageal reflux symptoms in asthma. Chest. 1996;109(2):316–322. doi:10.1378/chest.109.2.316.
   PubMed Web of Science ®Google Scholar
• Chipps BE, Haselkorn T, Paknis B, Ortiz B, Bleecker ER, Kianifard F, et al. More than a decade follow-up in patients with severe or difficult-to-treat asthma: The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) II. J Allergy Clin Immunol. 2018;141:1590–1597.e9. doi:10.1016/j.jaci.2017.07.014.
   Web of Science ®Google Scholar
• Bacon SL, Bouchard A, Loucks EB, Lavoie KL. Individual-level socioeconomic status is associated with worse asthma morbidity in patients with asthma. Respir Res. 2009;10(1):125–132. doi:10.1186/1465-9921-10-125.
   PubMed Web of Science ®Google Scholar
• Lynd LD, Sandford AJ, Kelly EM, Paré PD, Bai TR, FitzGerald JM, Anis AH. Reconcilable differences: a cross-sectional study of the relationship between socioeconomic status and the magnitude of short-acting β-agonist use in asthma. Chest. 2004;126(4):1161–1168.
   PubMedGoogle Scholar
• Durrington HJ, Farrow SN, Loudon AS, Ray DW. The circadian clock and asthma. Thorax. 2014;69(1):90–92. doi:10.1136/thoraxjnl-2013-203482.
   PubMed Web of Science ®Google Scholar
• Mello-Fujita L, Roizenblat S, Frison CR, Rodrigues Junior L, Garbuio S, Tufik S, Bittencourt LRA. Gastroesophageal reflux episodes in asthmatic patients and their temporal relation with sleep architecture. Braz J Med Biol Res. 2008;41(2):152–158. doi:10.1590/S0100-879X2008000200012.
   PubMed Web of Science ®Google Scholar
• Bohadana AB, Hannhart B, Teculescu DB. Nocturnal worsening of asthma and sleep-disordered breathing. J Asthma. 2002;39(2):85–100. doi:10.1081/JAS-120002190.
   PubMed Web of Science ®Google Scholar
• Strunk RC, Sternberg AL, Bacharier LB, Szefler SJ. Nocturnal awakening caused by asthma in children with mild-to-moderate asthma in the childhood asthma management program. J Allergy Clin Immunol. 2002;110(3):395–403. doi:10.1067/mai.2002.127433.
   PubMed Web of Science ®Google Scholar
• Hui Y, Li L, Qian J, Guo Y, Zhang X, Zhang X. Efficacy analysis of three-year subcutaneous SQ-standardized specific immunotherapy in house dust mite-allergic children with asthma. Exp Ther Med. 2014;7(3):630–634. doi:10.3892/etm.2014.1469.
   PubMed Web of Science ®Google Scholar
• Tian M, Lu YQ, Wang Y, Jiang YH, Zhao DY. [Long-term efficacy of sublingual immunotherapy with Dermatophagoides Farianae Drops in children with allergic asthma sensitized to dust mites]. [Article in Chinese]. Zhonghua Er Ke Za Zhi. 2013;51(10):741–744.
   PubMedGoogle Scholar
• Straumann A, Bauer M, Fischer B, Blaser K, Simon HU. Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol. 2001;108(6):954–961. doi:10.1067/mai.2001.119917.
   PubMed Web of Science ®Google Scholar
• Caldwell JM, Paul M, Rothenberg ME. Novel immunologic mechanisms in eosinophilic esophagitis. Curr Opin Immunol. 2017;48:114–121. doi:10.1016/j.coi.2017.08.006.
   PubMed Web of Science ®Google Scholar
• Martin LJ, He H, Collins MH, Abonia JP, Biagini Myers JM, Eby M, Johansson H, Kottyan LC, Khurana Hershey GK, Rothenberg ME, et al. Eosinophilic esophagitis (EoE) genetic susceptibility is mediated by synergistic interactions between EoE-specific and general atopic disease loci. J Allergy Clin Immunol.2018;141(5):1690–1698. doi:10.1016/j.jaci.2017.09.046.
   PubMed Web of Science ®Google Scholar
• Perić A, Vojvodić D, Vukomanović-Đurđević B, Baletić N. Eosinophilic inflammation in allergic rhinitis and nasal polyposis. Arh Hig Rada Toksikol. 2011;62(4):341–348. doi:10.2478/10004-1254-62-2011-2120.
   PubMed Web of Science ®Google Scholar
• Poznanovic SA, Kingdom TT. Total IgE levels and peripheral eosinophilia: correlation with mucosal disease based on computed tomographic imaging of the paranasal sinus. Arch Otolaryngol Head Neck Surg. 2007;133(7):701–704. doi:10.1001/archotol.133.7.701.
   PubMedGoogle Scholar
• Massanari M, Holgate ST, Busse WW, Jimenez P, Kianifard F, Zeldin R. Effect of omalizumab on peripheral blood eosinophilia in allergic asthma. Respir Med. 2010;104(2):188–196. doi:10.1016/j.rmed.2009.09.011.
   PubMed Web of Science ®Google Scholar
• Kupryś-Lipińska I, Molińska K, Kuna P. The effect of omalizumab on eosinophilic inflammation of the respiratory tract in patients with allergic asthma. Pneumonol Allergol Pol. 2016;84(4):232–243. doi:10.5603/PiAP.2016.0029.
   PubMedGoogle Scholar
• Sihra BS, Kon OM, Grant JA, Kay AB. Expression of high-affinity IgE receptors (Fc epsilon RI) on peripheral blood basophils, monocytes, and eosinophils in atopic and nonatopic subjects: relationship to total serum IgE concentrations. J Allergy Clin Immunol. 1997;99(5):699–706. doi:10.1016/S0091-6749(97)70033-2.
   PubMed Web of Science ®Google Scholar
• Lantero S, Alessandri G, Spallarossa D, Scarso L, Rossi GA. Stimulation of eosinophil IgE low-affinity receptor leads to increased adhesion molecule expression and cell migration. Eur Respir J. 2000;16(5):940–946. doi:10.1183/09031936.00.16594000.
   PubMed Web of Science ®Google Scholar
• Noga O, Hanf G, Kunkel G. Immunological and clinical changes in allergic asthmatics following treatment with omalizumab. Int Arch Allergy Immunol. 2003;131(1):46–52. doi:10.1159/000070434.
   PubMed Web of Science ®Google Scholar
• Haroon S, Adab P, Riley RD, Fitzmaurice D, Jordan RE. Predicting risk of undiagnosed COPD: development and validation of the TargetCOPD score. Eur Respir J. 2017;49(6):1602191. doi:10.1183/13993003.02191-2016.
   PubMed Web of Science ®Google Scholar